This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEB9M0BY_M.jpg
Pliant Therapeutics, Inc. (Nasdaq: PLRX) 11% HIGHER; announced it will host a conference call and webcast on Tuesday, September 26, 2023 at 8:00 a.m. ET | 5:00 a.m. PT to discuss the interim results from the INTEGRIS-PSC Phase 2a trial. Members of Pliant’s management will be joined by Gideon Hirschfield, FRCP, Ph.D., Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto and a principal investigator in the INTEGRIS-PSC trial.
Coty Inc . (NYSE:COTY) 5% LOWER; announced the launch of a global offering of 33 million shares of Coty’s outstanding Class A common stock.
